Results 31 to 40 of about 1,586 (155)

Correction: Blood cardioplegia or custodiol for myocardial protection during valvular or aortic surgery: a propensity score adjusted comparison [PDF]

open access: yesJournal of Cardiothoracic Surgery
Manuel Carnero-Alcazar   +9 more
doaj   +2 more sources

In situ reconstruction of distal renal artery aneurysm with renal perfusion: A case series

open access: yesAnnals of Vascular Surgery - Brief Reports and Innovations, 2023
The treatment of renal artery aneurysms located from the mid to distal portion of the vessel is challenging. The complexity is related to the frequent involvement of side branches and to the risk of postoperative renal impairment. We report five cases of
Francesca Montanari   +6 more
doaj   +1 more source

Custodiol (Histidine-Tryptophan-Ketoglutarate) versus Modified St. Thomas Cold Crystalloid Cardioplegia: Short-term Results [PDF]

open access: yesAl-Azhar International Medical Journal, 2020
Background: Myocardial protection refers to strategies used to avoid post-ischemic myocardial dysfunction. One dose approach for myocardial safety is attractive in long operations.
Ismail EL-Sokkary   +4 more
doaj   +1 more source

Comparison of HTK-Custodiol and St-Thomas solution as cardiac preservation solutions on early and midterm outcomes following heart transplantation. [PDF]

open access: yesInterdiscip Cardiovasc Thorac Surg
peer reviewed[en] OBJECTIVES: The choice of the cardiac preservation solution for myocardial protection at time of heart procurement remains controversial and uncertainties persist regarding its effect on the early and midterm heart transplantation (HTx)
Dulguerov F   +15 more
europepmc   +4 more sources

Comparison between Custodiol, del Nido and modified del Nido in the myocardial protection - Cardioplegia Trial: a study protocol for a randomised, double-blind clinical trial

open access: yesBMJ Open, 2021
Introduction Myocardial protection is essential for successful cardiac surgery, and the search for an ideal cardioplegic solution has continued since its beginning.
Adriana Silveira Almeida   +9 more
doaj   +1 more source

Comparative Study Between Custodiol® versus Cold Blood Cardioplegia for Myocardial Protection in Double Valve Replacement Surgery [PDF]

open access: yes, 2021
Background: Several cardioplegic solutions are available for myocardial preservation. The superiority of intracellular over extracellular cardioplegia is still debated.
Rezk, Moataz   +9 more
core   +1 more source

Beneficial Effects of RNS60 in Cardiac Ischemic Injury

open access: yesCurrent Issues in Molecular Biology, 2022
RNS60 is a physically modified saline solution hypothesized to contain oxygen nanobubbles. It has been reported to reduce ischemia/reperfusion injury in a pig model of acute myocardial infarction.
Magdalena A. Zabielska-Kaczorowska   +5 more
doaj   +1 more source

Prediction Model for Contractile Function of Circulatory Death Donor Hearts Based on Microvascular Flow Shifts During Ex Situ Hypothermic Cardioplegic Machine Perfusion

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Hearts procured from circulatory death donors (DCD) are predominantly maintained by machine perfusion (MP) with normothermic donor blood. Currently, DCD heart function is evaluated by lactate and visual inspection.
Lars Saemann   +8 more
doaj   +1 more source

CUSTODIOL CARDIOPLEGIA: WHICH PROTOCOL TO PREFER?

open access: yes, 2017
In this review we presented data about the basic Custodiol cardioplegia techniques and protocols, adverse site effects and warnings. National and international articles on the use of Custodiol cardiople- gia in cardiopulmonary bypass surgery were ...
I S Kurapeev   +5 more
core   +1 more source

Effects of Custodiol-N, a novel organ preservation solution, on ischemia/reperfusion injury [PDF]

open access: yes, 2009
ObjectiveCustodiol (histidine-tryptophan-ketoglutarate solution) is a leading organ preservation solution. On the basis of this solution, the novel Custodiol-N was developed.
Karck, Matthias   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy